Deep cfDNA fragment end profiling enables cancer detection

Mol Cancer. 2022 Jan 21;21(1):26. doi: 10.1186/s12943-021-01491-8.
No abstract available

Keywords: Colorectal cancer; Early cancer detection; Fragmentomics; Liquid biopsy; Renal cancer; cfDNA; cfDNA-FEP.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor*
  • Case-Control Studies
  • Cell-Free Nucleic Acids*
  • Circulating Tumor DNA*
  • Disease Management
  • Disease Susceptibility
  • Early Detection of Cancer
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Liquid Biopsy / methods*
  • Liquid Biopsy / standards
  • Neoplasms / diagnosis*
  • Neoplasms / genetics*
  • Reactive Oxygen Species / metabolism

Substances

  • Biomarkers, Tumor
  • Cell-Free Nucleic Acids
  • Circulating Tumor DNA
  • Reactive Oxygen Species